Physician profile
Carrie A Smith
NPI 1053573733
$1,609.00
in general payments reported to CMS, 2019-2025
24 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $28.26 · 2022: $384 · 2023: $265 · 2024: $453 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $858 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.52 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $284.84 | 2022-2025 | Veozah |
| Abbvie INC. | $253.94 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Coopersurgical, INC. | $175.22 | 2019-2025 | Paragard T 380a, Sos, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $146.31 | 2019-2025 | |
| Exeltis, USA INC. | $115.74 | 2022-2025 | Slynd |
| Therapeuticsmd, INC. | $89.16 | 2019-2022 | |
| Pfizer INC. | $88.58 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $83.83 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $51.47 | 2022 | |
| Axonics, INC. | $43.00 | 2024 | Axonics |
| Sumitomo Pharma America, INC. | $41.73 | 2024 | Gemtesa, Myfembree |
| Ethicon US, LLC | $36.56 | 2023 | Echelon Circular, Endopath, Echelon Flex |
| Medtronic, INC. | $23.70 | 2022 | |
| Exact Sciences Corporation | $21.67 | 2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $21.32 | 2025 | General - Therapies |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $19.66 | 2024 | |
| Coloplast Corp | $17.16 | 2024 | |
| Vertical Pharmaceuticals, LLC | $16.13 | 2019 | |
| Mylan Pharmaceuticals INC. | $15.41 | 2022 | |
| Organon LLC | $14.55 | 2024 | |
| Duchesnay USA Incorporated | $13.38 | 2019 | |
| Minerva Surgical, INC | $12.20 | 2022 | |
| Covidien LP | $12.03 | 2019 | |
| Mission Pharmacal Company | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.